R 56865
CAS: 104606-13-5
Ref. TM-T26016
| 1mg | 278.00 € | ||
| 5mg | 684.00 € | ||
| 10mg | 935.00 € | ||
| 25mg | 1,410.00 € | ||
| 50mg | 1,845.00 € | ||
| 100mg | 2,329.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Product Information
Name:
R 56865
Synonyms:
- R56865
- N-[1-[4-(4-Fluorophenoxy)butyl]-4-piperidinyl]-N-methyl-2-benzothiazolamine
- 2-Benzothiazolamine, N-[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-N-methyl-
Description:
R 56865 is a weak potential-operated channel inhibitor that inhibits the late sodium current in human isolated cardiomyocytes.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
413.55
Formula:
C23H28FN3OS
Purity:
99.08%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T26016 R 56865
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
